Thiamine Mononitrate (Vitamin B1) Market Size & Share, by Type (Food Grade, Feed Grade, Pharmaceutical Grade); Application (Supplements, Feed Additives, Cosmetics); Distribution Channel (Online, Offline) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4064
  • Published Date: Mar 16, 2023
  • Report Format: PDF, PPT

Companies Dominating the Thiamine Mononitrate (Vitamin B1) Landscape

top-features-companies
    • Brother Enterprises Holding Co., Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BASF SE
    • Jiangxi Tianxin Pharmaceutical Co., Ltd.
    • Koninklijke DSM N.V.
    • Supreem Pharmaceuticals Mysore Pvt. Ltd.
    • Saltvae Pharmaceuticals Private Limited
    • Charles Bowman and Company
    • Huazhong Pharmaceutical Co., Ltd.
    • Xinfa Pharmaceutical Co. Ltd.
    • CMG BIOTECH PRIVATE LIMITED

Browse Key Market Insights with Data Illustration:

In the News

  • Koninklijke DSM N.V. has acquired Midori USA, Inc., a biotechnology start-up with a cutting-edge precision platform creating ground-breaking targeted eubiotics that enhance the well-being and ecological impact of animals.

  • Koninklijke DSM N.V. has updated its OVN Optimal Vitamin Nutrition standards to promote sustainable farming methods. OVN, which has a low environmental impact, enhances animal health and welfare by giving animals the right amount of superior vitamins.


Author Credits:  Smruti Ranjan, Rajrani Baghel


  • Report ID: 4064
  • Published Date: Mar 16, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand The surge in the underweight issue, the worldwide rising geriatric population, and an upsurge in the demand for health supplements are the major factors driving the market growth.vitamin B1 supplements is estimated to boost the market growth.

The market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2035.

High cost of thiamine mononitrate, and a dearth of awareness regarding the benefits of thiamine in emerging nations are estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Brother Enterprises Holding Co., Ltd., BASF SE, Jiangxi Tianxin Pharmaceutical Co., Ltd., Koninklijke DSM N.V., Supreem Pharmaceuticals Mysore Pvt. Ltd., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, distribution channel, and region.

The pharmaceutical grade segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying